Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 51 Records) |
Query Trace: Death and ERCC1[original query] |
---|
Multiple analytical approaches demonstrate a complex relationship of genetic and nongenetic factors with cisplatin- and carboplatin-induced nephrotoxicity in lung cancer patients. BioMed research international 2014 2014 937429. Liu H Eugene, Bai Kuan-Jen, Hsieh Yu-Chen, Yu Ming-Chih, Lee Chun-Nin, Chang Jer-Hua, Hsu Han-Lin, Lu Pei-Chih, Chen Hsiang-Y |
Association of DNA repair gene polymorphisms with response to chemotherapy and prognosis of gastric cancer. Genetics and molecular research : GMR 2014 13 (3): 7484-91. Chen Z H, Wang L, Luo L |
Associations of polymorphisms in DNA repair genes and MDR1 gene with chemotherapy response and survival of non-small cell lung cancer. PloS one 2014 9 (6): e99843. Du Yan, Su Tong, Zhao Lijun, Tan Xiaojie, Chang Wenjun, Zhang Hongwei, Cao Guangw |
Effect of ERCC1 polymorphism on the response to chemotherapy and clinical outcome of non-small cell lung cancer. Genetics and molecular research : GMR 2014 13 (4): 8997-9004. Gao H, Ge R C, Liu H Y, Wang Y, Yan |
Association between ERCC1 and ERCC2 gene polymorphisms and chemotherapy response and overall survival in osteosarcoma. Genetics and molecular research : GMR 2015 14 (3): 10145-51. Cao Z H, Yin H P, Jiang N, Yu |
Genetic polymorphisms in nucleotide excision repair pathway influences response to chemotherapy and overall survival in osteosarcoma. International journal of clinical and experimental pathology 2015 8 (7): 7905-12. Sun Yongjian, Wu Yi, Li Weicheng, Kong Zhen, Zou Xiaomi |
Genetic variability of genes in NER pathway influences the treatment outcome of gastric cancer. International journal of clinical and experimental pathology 2015 8 (5): 5563-9. Xue Ming-Hui, Li Guang-Yan, Wu Xin-Jun, Zhang Chao-Xian, Zhang Cai-Feng, Zhu Kong- |
Investigation on the DNA repaired gene polymorphisms and response to chemotherapy and overall survival of osteosarcoma. International journal of clinical and experimental pathology 2015 8 (1): 894-9. Ji Wei-Ping, He Neng-B |
Genetic variability of genes involved in DNA repair influence treatment outcome in osteosarcoma. Genetics and molecular research : GMR 2015 14 (3): 11652-7. Wang M J, Zhu Y, Guo X J, Tian Z |
Prognostic significance of head and neck squamous cell carcinoma repair gene polymorphism. Genetics and molecular research : GMR 2015 14 (4): 12446-54. Stur E, Agostini L P, Garcia F M, Peterle G T, Maia L L, Mendes S O, Anders Q S, Reis R S, Santos J A, Ventorim D P, Carvalho M B, Tajara E H, Santos M, Paula F, Silva-Conforti A M A, Louro I |
Polymorphisms of multiple genes involved in NER pathway predict prognosis of gastric cancer. Oncotarget 2016 Jun . Liu Jingwei, Deng Na, Xu Qian, Sun Liping, Tu Huakang, Wang Zhenning, Xing Chengzhong, Yuan Yu |
Genetic variability of ERCC1 and ERCC2 genes involved in the nucleotide excision repair pathway influences the treatment outcome of gastric cancer. Genetics and molecular research : GMR 2016 15 (2): . Zheng D L, Tang G D, Chen Y N, Zhang T, Qin M |
XPD c.934G>A polymorphism of nucleotide excision repair pathway in outcome of head and neck squamous cell carcinoma patients treated with cisplatin chemoradiation. Oncotarget 2016 Feb . Lopes-Aguiar Leisa, Costa Ericka Francislaine Dias, Nogueira Guilherme Augusto Silva, Lima Tathiane Regine Penna, Visacri Marília Berlofa, Pincinato Eder Carvalho, Calonga Luciane, Mariano Fernanda Viviane, Altemani Albina Messias de Almeida Milani, Altemani João Maurício Carrasco, Coutinho-Camillo Cláudia Malheiros, Alves Maria Almerinda Vieira Fernandes Ribeiro, Moriel Patrícia, Ramos Celso Dario, Chone Carlos Takahiro, Lima Carmen Silvia Pass |
Roles of XRCC1/XPD/ERCC1 Polymorphisms in Predicting Prognosis of Hepatocellular Carcinoma in Patients Receiving Transcatheter Arterial Chemoembolization. Genetic testing and molecular biomarkers 2016 Feb . Wang Xu-Cai, Wang Fan, Quan Qing-Qi |
Prognostic value of ERCC1 and ERCC2 gene polymorphisms in patients with gastric cancer receiving platinum-based chemotherapy. International journal of clinical and experimental pathology 2015 8 (11): 15065-71. Mo Juanmei, Luo Min, Cui Jiandong, Zhou Shaozha |
Genetic variability of ERCC1 genes in NER pathway influences the treatment outcome of gastric cancer. International journal of clinical and experimental pathology 2015 8 (10): 13367-73. Bai Yu, Wang Lei, Li Guangjun, Fang Xiangjie, Li Yan, Yang Shuju |
Functional genetic variants of XRCC4 and ERCC1 predict survival of gastric cancer patients treated with chemotherapy by regulating the gene expression. Molecular carcinogenesis 2017 Aug . Cheng Lei, Qiu Lixin, Wang Mengyun, Zhang Ruoxin, Sun Menghong, Zhu Xiaodong, Wang Yanong, Wei Qing |
Impact of DNA repair, folate and glutathione gene polymorphisms on risk of non small cell lung cancer. Pathology, research and practice 2017 Nov . Pérez-Ramírez Cristina, Cañadas-Garre Marisa, Alnatsha Ahmed, Villar Eduardo, Delgado Juan Ramón, Calleja-Hernández Miguel Ángel, Faus-Dáder María Jo |
Genetic variants as ovarian cancer first-line treatment hallmarks: A systematic review and meta-analysis. Cancer treatment reviews 2017 Dec 61 35-52. Assis Joana, Pereira Carina, Nogueira Augusto, Pereira Deolinda, Carreira Rafael, Medeiros R |
The Utility of Thyroid Transcription Factor 1 (TTF-1), Napsin A, Excision Repair Cross-Complementing 1 (ERCC1), Anaplastic Lymphoma Kinase (ALK) and the Epidermal Growth Factor Receptor (EGFR) Expression in Small Biopsy in Prognosis of Patients with Lung Adenocarcinoma - A Retrograde Single-Center Study from Croatia. Medical science monitor : international medical journal of experimental and clinical research 2017 Jan 23 489-497. Pilji? Burazer Marina, Mladinov Suzana, ?apkun Vesna, Kuret Sendi, Glavina Durdov Meri |
The effect of ERCC1 and ERCC2 gene polymorphysims on response to cisplatin based therapy in osteosarcoma patients. BMC medical genetics 2018 Jul 19 (1): 112. Obiedat Hadeel, Alrabadi Nasr, Sultan Eyad, Al Shatti Marwa, Zihlif Mal |
Pharmacogenetics of platinum-based chemotherapy: impact of DNA repair and folate metabolism gene polymorphisms on prognosis of non-small cell lung cancer patients. The pharmacogenomics journal 2018 Apr . Pérez-Ramírez Cristina, Cañadas-Garre Marisa, Alnatsha Ahmed, Villar Eduardo, Valdivia-Bautista Javier, Faus-Dáder María José, Calleja-Hernández Miguel Áng |
[Pharmacogenetics, tobacco, alcohol and its effect on the risk development cancer]. Revista chilena de pediatria 2018 12 89 (4): 432-440. Roco Ángela, Cerda Berta, Cayún Juan Pablo, Lavanderos Alejandra, Rubilar Juan Carlos, Cerro Roberto, Acevedo Christian, Cáceres Dante, Varela Nelson, Quiñones Luis |
Polymorphisms in ERCC5 rs17655 and ERCC1 rs735482 Genes Associated with the Survival of Male Patients with Postoperative Oral Squamous Cell Carcinoma Treated with Adjuvant Concurrent Chemoradiotherapy. Journal of clinical medicine 2019 1 8 (1): . Senghore Thomas, Chien Huei-Tzu, Wang Wen-Chang, Chen You-Xin, Young Chi-Kuang, Huang Shiang-Fu, Yeh Chih-Chi |
Early-onset nucleotide excision repair disorders with neurological impairment: Clues for early diagnosis and prognostic counseling. Clinical genetics 2020 6 98 (3): 251-260. Baer Sarah, Obringer Cathy, Julia Sophie, Chelly Jameleddine, Capri Yline, Gras Domitille, Baujat Geneviève, Felix Têmis Maria, Doray Berenice, Sanchez Del Pozo Jaime, Ramos Lina M, Burglen Lydie, Laugel Vincent, Calmels Nadè |
Role of common ERCC1 polymorphisms in cisplatin-resistant epithelial ovarian cancer patients: A study in Chinese cohort. International journal of immunogenetics 2020 3 47 (5): 443-453. Bao Yuxia, Yang Bin, Zhao Jingjiao, Shen Simin, Gao Jianyu |
The association between the ERCC1/2 polymorphisms and radiotherapy efficacy in 87 patients with non-small cell lung cancer. Journal of thoracic disease 2021 6 13 (5): 3126-3136. Jiang Chenxue, Guo Yanling, Li Yefei, Kang Jingjing, Sun Xiaojiang, Wu Hongyu, Feng Jianguo, Xu Yapi |
Genotyping, in silico screening and molecular dynamics simulation of SNPs of MGMT and ERCC1 gene in lung cancer patients treated with platinum-based doublet chemotherapy. Journal of biomolecular structure & dynamics 2023 9 1-20. Sidhartha Singh, Anu Gupta, Navneet Singh, Parth Sarthi Sengupta, Saroj Kumar Panda, Siddharth Shar |
Elevated sHLA-G plasma levels post chemotherapy combined with ILT-2 rs10416697C allele status of the sHLA-G-related receptor predict poorest disease outcome in early triple-negative breast cancer patients. Frontiers in immunology 2023 6 14 1188030. Oliver Hoffmann, Sebastian Wormland, Ann-Kathrin Bittner, Julian Hölzenbein, Esther Schwich, Sabine Schramm, Hana Rohn, Peter A Horn, Rainer Kimmig, Sabine Kasimir-Bauer, Vera Rebma |
Genetic variability in cisplatin metabolic pathways and outcome of locally advanced head and neck squamous cell carcinoma patients. Scientific reports 2023 10 13 (1): 16762. Ana Maria Castro Ferreira, João Maurício Carrasco Altemani, Ligia Traldi Macedo, Gustavo Jacob Lourenço, Carmen Silvia Passos Li |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: